RhoGEFs in cell motility: Novel links between Rgnef and focal adhesion kinase

Current Molecular Medicine

Volumn 14, Issue 2, 2014, Pages 221-234

  Miller, N L G ^a   Kleinschmidt, E G ^a,b   Schlaepfer, D D ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cell motility; Dbl related GEF; FAK; Integrin signaling; Rgnef ARHGEF28; RhoGTPase

Indexed keywords

FIBRONECTIN; FOCAL ADHESION KINASE; GUANOSINE DIPHOSPHATE; GUANOSINE TRIPHOSPHATASE; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; GUANOSINE TRIPHOSPHATE; INTEGRIN; MESSENGER RNA; PROTEIN TYROSINE KINASE; RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR;

ANGIOGENESIS; ARTICLE; CARCINOGENESIS; CELL ADHESION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CELL SURVIVAL; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LARGE CELL LYMPHOMA; METASTASIS; NEOPLASM; NUCLEOTIDE SEQUENCE; PLECKSTRIN HOMOLOGY; PROTEIN STRUCTURE; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TUMOR GROWTH; TUMOR INVASION;

ANIMALS; CELL MOVEMENT; FOCAL ADHESION PROTEIN-TYROSINE KINASES; HUMANS; MODELS, BIOLOGICAL; RHO GUANINE NUCLEOTIDE EXCHANGE FACTORS;

EID: 84896726808     PISSN: 15665240     EISSN: 18755666     Source Type: Journal    
DOI: 10.2174/1566524014666140128110339     Document Type: Article

References (192)

1. Moissoglu K, Schwartz MA. Integrin signalling in directed cell migration. Biol Cell 2006; 98(9): 547-555.
2. Geiger B, Spatz JP, Bershadsky AD. Environmental sensing through focal adhesions. Nat Revs Mol Cell Biol 2009; 10(1): 21-33.
3. Ridley AJ, Schwartz MA, Burridge K, et al. Cell migration: integrating signals from front to back. Science 2003; 302(5651): 1704-1709.
4. Gardel ML, Schneider IC, Aratyn-Schaus Y, Waterman CM. Mechanical integration of actin and adhesion dynamics in cell migration. Annu Rev Cell Dev Biol 2010; 26: 315-333.
5. Shattil SJ, Kim C, Ginsberg MH. The final steps of integrin activation: the end game. Nat Rev Mol Cell Biol 2010; 11(4): 288-300.
6. Parsons JT, Horwitz AR, Schwartz MA. Cell adhesion: integrating cytoskeletal dynamics and cellular tension. Nat Rev Mol Cell Biol 2010; 11(9): 633-643.
7. Hall A. Rho GTPases and the control of cell behaviour. Biochem Soc Trans 2005; 33(Pt 5): 891-895.
8. Jaffe AB, Hall A. Rho GTPases: biochemistry and biology. Annu Rev Cell Dev Biol 2005; 21: 247-269.
9. Bos JL, Rehmann H, Wittinghofer A. GEFs and GAPs: critical elements in the control of small G proteins. Cell 2007; 129(5): 865-877.
10. Rossman KL, Der CJ, Sondek J. GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors. Nat Rev Mol Cell Biol 2005; 6(2): 167-180.
11. Ligeti E, Welti S, Scheffzek K. Inhibition and termination of physiological responses by GTPase activating proteins. Physiol Rev 2012; 92(1): 237-272.
12. Mizuno-Yamasaki E, Rivera-Molina F, Novick P. GTPase networks in membrane traffic. Annu Rev Biochem 2012; 81: 637-659.
13. K. Snapshots form a big picture of guanine nucleotide exchange. Sci Signal 2009; 2(91): p e63.
14. Pakes NK, Veltman DM, Williams RS. Zizimin and Dock guanine nucleotide exchange factors in cell function and disease. Small GTPases 2013; 4(1): 22-27.
15. Jaiswal M, Dvorsky R, Ahmadian MR. Deciphering the molecular and functional basis of Dbl family proteins: a novel systematic approach toward classification of selective activation of the Rho family proteins. J Biol Chem 2013; 288(6): 4486-4500.
16. Soisson SM, Nimnual AS, Uy M, Bar-Sagi D, Kuriyan J. Crystal structure of the Dbl and pleckstrin homology domains from the human Son of sevenless protein. Cell 1998; 95(2): 259-268.
17. Lemmon MA. Pleckstrin homology domains: not just for phosphoinositides. Biochem Soc Trans 2004; 32(Pt 5): 707-711.
18. Lemmon MA. Membrane recognition by phospholipid-binding domains. Nat Rev Mol Cell Biol 2008; 9(2): 99-111.
19. Viaud J, Gaits-Iacovoni F, Payrastre B. Regulation of the DH-PH tandem of guanine nucleotide exchange factor for Rho GTPases by phosphoinositides. Adv Biol Regul 2012; 52(2): 303-314.
20. Gebbink MF, Kranenburg O, Poland M, van Horck FP, Houssa B, Moolenaar WH. Identification of a novel, putative Rho-specific GDP/GTP exchange factor and a RhoA-binding protein: control of neuronal morphology. J Cell Biol 1997; 137(7): 1603-1613.
21. van Horck FP, Ahmadian MR, Haeusler LC, Moolenaar WH, Kranenburg O. Characterization of p190RhoGEF, a RhoA-specific guanine nucleotide exchange factor that interacts with microtubules. J Biol Chem 2001; 276(7): 4948-4956.
22. Bravo-Cordero JJ, Oser M, Chen X, Eddy R, Hodgson L, Condeelis J. A Novel Spatiotemporal RhoC Activation Pathway Locally Regulates Cofilin Activity at Invadopodia. Curr Biol 2011; 21(8): 635-644.
23. Canete-Soler R, Wu J, Zhai J, Shamim M, Schlaepfer WW. p190RhoGEF Binds to a destabilizing element in the 3' untranslated region of light neurofilament subunit mRNA and alters the stability of the transcript. J Biol Chem 2001; 276(34): 32046-32050.
24. Zhai J, Lin H, Shamim M, Schlaepfer WW, Canete-Soler R. Identification of a novel interaction of 14-3-3 with p190RhoGEF. J Biol Chem 2001; 276(44): 41318-41324.
25. Meyer D, Liu A, Margolis B. Interaction of c-Jun amino-terminal kinase interacting protein-1 with p190RhoGEF and its localization in differentiated neurons. J Biol Chem 1999; 274(49): 35113-35118.
26. Garcia-Mata R, Burridge K. Catching a GEF by its tail. Trends Cell Biol 2007; 17(1): 36-43.
27. Chi CN, Bach A, Stromgaard K, Gianni S, Jemth P. Ligand binding by PDZ domains. Biofactors 2012; 38(5): 338-348.
28. Zhai J, Lin H, Nie Z, et al. Direct interaction of focal adhesion kinase with p190RhoGEF. J Biol Chem 2003; 278(27): 24865-24873.
29. Lim Y, Lim ST, Tomar A, et al. PyK2 and FAK connections to p190RhoGEF regulate RhoA activity, focal adhesion formation, and cell motility. J Cell Biol 2008; 180(1): 187-203.
30. Schaller MD. Cellular functions of FAK kinases: insight into molecular mechanisms and novel functions. J Cell Sci 2010; 123(Pt 7): 1007-1013.
31. Mitra SK, Hanson DA, Schlaepfer DD. Focal adhesion kinase: in command and control of cell motility. Nat Rev Mol Cell Biol 2005; 6(1): 56-68.
32. Schlaepfer DD, Hauck CR, Sieg DJ. Signaling through focal adhesion kinase. Prog Biophys Mol Biol 1999; 71: 435-478.
33. Zhao X, Peng X, Sun S, Park AY, Guan JL. Role of kinase-independent and -dependent functions of FAK in endothelial cell survival and barrier function during embryonic development. J Cell Biol 2010; 189(6): 955-965.
34. Lim ST, Chen XL, Tomar A, Miller NL, Yoo J, Schlaepfer DD. Knock-in mutation reveals an essential role for focal adhesion kinase activity in blood vessel morphogenesis and cell motility-polarity but not cell proliferation. J Biol Chem 2010; 285(28): 21526-21536.
35. Chen XL, Nam JO, Jean C, et al. VEGF-induced vascular permeability is mediated by FAK. Dev Cell 2012; 22(1): 146-157.
36. Parsons JT, Slack-Davis J, Tilghman R, Roberts WG. Focal adhesion kinase: targeting adhesion signaling pathways for therapeutic intervention. Clin Cancer Res 2008; 14(3): 627-632.
37. Yu HG, Nam JO, Miller NL, et al. p190RhoGEF (Rgnef) promotes colon carcinoma tumor progression via interaction with focal adhesion kinase. Cancer Res 2011; 71(2): 360-370.
38. Miller NL, Lawson C, Kleinschmidt EG, Tancioni I, Uryu S, Schlaepfer DD. A non-canonical role for Rgnef in promoting integrin-stimulated focal adhesion kinase activation. J Cell Sci 2013; 126(Pt 21): 5074-5085.
39. Perrimon N, Pitsouli C, Shilo BZ. Signaling mechanisms controlling cell fate and embryonic patterning. CSH Perspect Biol 2012; 4(8): a005975.
40. Lim J, Thiery JP. Epithelial-mesenchymal transitions: insights from development. Development 2012; 139(19): 3471-3486.
41. Liu AX, Rane N, Liu JP, Prendergast GC. RhoB is dispensable for mouse development, but it modifies susceptibility to tumor formation as well as cell adhesion and growth factor signaling in transformed cells. Mol Cell Biol 2001; 21(20): 6906-6912.
42. Pedersen E, Brakebusch C. Rho GTPase function in development: how in vivo models change our view. Exp Cell Res 2012; 318(14): 1779-1787.
43. Hakem A, Sanchez-Sweatman O, You-Ten A, et al. RhoC is dispensable for embryogenesis and tumor initiation but essential for metastasis. Genes Dev 2005; 19(17): 1974-1979.
44. Miller NL, Lawson C, Chen XL, Lim ST, Schlaepfer DD. Rgnef (p190RhoGEF) knockout inhibits RhoA activity, focal adhesion establishment, and cell motility downstream of integrins. PLoS One 2012; 7(5): e37830.
45. Samson T, van Buul JD, Kroon J, et al. The guanine-nucleotide exchange factor SGEF plays a crucial role in the formation of atherosclerosis. PLoS One 2013; 8(1): e55202.
46. Kim H, Han JR, Park J, et al. Delta-catenin-induced dendritic morphogenesis. An essential role of p190RhoGEF interaction through Akt1-mediated phosphorylation. J Biol Chem 2008; 283(2): 977-987.
47. Droppelmann CA, Keller BA, Campos-Melo D, Volkening K, Strong MJ. Rho guanine nucleotide exchange factor is an NFL mRNA destabilizing factor that forms cytoplasmic inclusions in amyotrophic lateral sclerosis. Neurobiol Aging 2013; 34(1): 248-262.
48. Lee JR, Ha YJ, Kim HJ. Cutting edge: induced expression of a RhoA-specific guanine nucleotide exchange factor, p190RhoGEF, following CD40 stimulation and WEHI 231 B cell activation. J Immunol 2003; 170(1): 19-23.
49. Ha YJ, Jeong JH, Park Y, Lee JR. Increased p190RhoGEF expression in activated B cells correlates with the induction of the plasma cell differentiation. Exp Mol Med 2012; 44(2): 138-148.
50. Mayers CM, Wadell J, McLean K, et al. The Rho guanine nucleotide exchange factor AKAP13 (BRX) is essential for cardiac development in mice. J Biol Chem 2010; 285(16): 12344-12354.
51. Qian X, Esteban L, Vass WC, et al. The Sos1 and Sos2 Ras-specific exchange factors: differences in placental expression and signaling properties. EMBO J 2000; 19(4): 642-654.
52. Cook DR, Solski PA, Bultman SJ, et al. The ect2 rho Guanine nucleotide exchange factor is essential for early mouse development and normal cell cytokinesis and migration. Genes Cancer 2011; 2(10): 932-942.
53. O'Brien SP, Seipel K, Medley QG, Bronson R, Segal R, Streuli M. Skeletal muscle deformity and neuronal disorder in Trio exchange factor-deficient mouse embryos. Proc Natl Acad Sci U S A 2000; 97(22): 12074-12078.
54. Thumkeo D, Keel J, Ishizaki T, et al. Targeted disruption of the mouse rho-associated kinase 2 gene results in intrauterine growth retardation and fetal death. Mol Cell Biol 2003; 23(14): 5043-5055.
55. Shimizu Y, Thumkeo D, Keel J, et al. ROCK-I regulates closure of the eyelids and ventral body wall by inducing assembly of actomyosin bundles. J Cell Biol 2005; 168(6): 941-953.
56. Rubtsov A, Strauch P, Digiacomo A, Hu J, Pelanda R, Torres RM. Lsc regulates marginal-zone B cell migration and adhesion and is required for the IgM T-dependent antibody response. Immunity 2005; 23(5): 527-538.
57. Francis SA, Shen X, Young JB, Kaul P, Lerner DJ. Rho GEF Lsc is required for normal polarization, migration, and adhesion of formyl-peptide-stimulated neutrophils. Blood 2006; 107(4): 1627-1635.
58. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell 2002; 110(6): 673-687.
59. Huveneers S, Danen EH. Adhesion signaling - crosstalk between integrins, Src and Rho. J Cell Sci 2009; 122(Pt 8): 1059-1069.
60. Pertz O, Hodgson L, Klemke RL, Hahn KM. Spatiotemporal dynamics of RhoA activity in migrating cells. Nature 2006; 440(7087): 1069-1072.
61. Tomar A, Schlaepfer DD. Focal adhesion kinase: switching between GAPs and GEFs in the regulation of cell motility. Curr Opin Cell Biol 2009; 21: 676-683.
62. Ren XD, Kiosses WB, Schwartz MA. Regulation of the small GTP-binding protein Rho by cell adhesion and the cytoskeleton. EMBO J 1999; 18(3): 578-585.
63. Vicente-Manzanares M, Webb DJ, Horwitz AR. Cell migration at a glance. J Cell Sci. 2005;118(Pt 21):4917-4919.
64. Tomar A, Lim ST, Lim Y, Schlaepfer DD. A FAK-p120RasGAP-p190RhoGAP complex regulates polarity in migrating cells. J Cell Sci 2009; 122(Pt 11): 1852-1862.
65. Arthur WT, Burridge K. RhoA inactivation by p190RhoGAP regulates cell spreading and migration by promoting membrane protrusion and polarity. Mol Biol Cell 2001; 12(9): 2711-2720.
66. Dubash AD, Wennerberg K, Garcia-Mata R, Menold MM, Arthur WT, Burridge K. A novel role for Lsc/p115 RhoGEF and LARG in regulating RhoA activity downstream of adhesion to fibronectin. J Cell Sci 2007; 120(Pt 22): 3989-3998.
67. Nalbant P, Chang YC, Birkenfeld J, Chang ZF, Bokoch GM. Guanine nucleotide exchange factor-H1 regulates cell migration via localized activation of RhoA at the leading edge. Mol Biol Cell 2009; 20(18): 4070-4082.
68. Parsons JT. Focal adhesion kinase: the first ten years. J Cell Sci 2003; 116(Pt 8): 1409-1416.
69. Choi CK, Zareno J, Digman MA, Gratton E, Horwitz AR. Cross-correlated fluctuation analysis reveals phosphorylation-regulated paxillin-FAK complexes in nascent adhesions. Biophys J 2011; 100(3): 583-592.
70. Hagel M, George EL, Kim A, et al. The adaptor protein paxillin is essential for normal development in the mouse and is a critical transducer of fibronectin signaling. Mol Cell Biol 2002; 22(3): 901-915.
71. Scheswohl DM, Harrell JR, Rajfur Z, Gao G, Campbell SL, Schaller MD. Multiple paxillin binding sites regulate FAK function. J Mol Signal 2008; 3: 1.
72. Lawson C, Lim ST, Uryu S, Chen XL, Calderwood DA, Schlaepfer DD. FAK promotes recruitment of talin to nascent adhesions to control cell motility. J Cell Biol 2012; 196(2): 223-232.
73. Lawson C, Schlaepfer DD. Integrin adhesions: who's on first? What's on second? Connections between FAK and talin. Cell Adh Migr 2012; 6(4): 302-306.
74. Rico B, Beggs HE, Schahin-Reed D, Kimes N, Schmidt A, Reichardt LF. Control of axonal branching and synapse formation by focal adhesion kinase. Nat Neurosci 2004; 7(10): 1059-1069.
75. Pasapera AM, Schneider IC, Rericha E, Schlaepfer DD, Waterman CM. Myosin II activity regulates vinculin recruitment to focal adhesions through FAK-mediated paxillin phosphorylation. J Cell Biol 2010; 188(6): 877-890.
76. Narumiya S, Tanji M, Ishizaki T. Rho signaling, ROCK and mDia1, in transformation, metastasis and invasion. Cancer Metastasis Rev 2009; 28(1-2): 65-76.
77. Frame MC, Patel H, Serrels B, Lietha D, Eck MJ. The FERM domain: organizing the structure and function of FAK. Nat Rev Mol Cell Biol 2010; 11(11): 802-814.
78. Toutant M, Costa A, Studler JM, Kadare G, Carnaud M, Girault JA. Alternative splicing controls the mechanisms of FAK autophosphorylation. Mol Cell Biol 2002; 22(22): 7731-7743.
79. Medina F, Carter AM, Dada O, et al. Activated RhoA is a Positive Feedback Regulator of the Lbc family of Rho guanine nucleotide exchange factor proteins. J Biol Chem 2013; 288(16): 11325-11333.
80. Jaffe AB, Aspenstrom P, Hall A. Human CNK1 acts as a scaffold protein, linking Rho and Ras signal transduction pathways. Mol Cell Biol 2004; 24(4): 1736-1746.
81. Jezyk MR, Snyder JT, Gershberg S, Worthylake DK, Harden TK, Sondek J. Crystal structure of Rac1 bound to its effector phospholipase C-beta2. Nat Struct Mol Biol 2006; 13(12): 1135-1140.
82. Chen Z, Medina F, Liu MY, Thomas C, Sprang SR, Sternweis PC. Activated RhoA binds to the pleckstrin homology (PH) domain of PDZ-RhoGEF, a potential site for autoregulation. J Biol Chem 2010; 285(27): 21070-21081.
83. Zhao J, Guan JL. Signal transduction by focal adhesion kinase in cancer. Cancer Met Rev 2009; 28(1-2): 35-49.
84. Roberts WG, Ung E, Whalen P, et al. Antitumor activity and pharmacology of a selective focal adhesion kinase inhibitor, PF-562,271. Cancer Res 2008; 68(6): 1935-1944.
85. Halder J, Lin YG, Merritt WM, et al. Therapeutic efficacy of a novel focal adhesion kinase inhibitor TAE226 in ovarian carcinoma. Cancer Res 2007; 67(22): 10976-10983.
86. Tanjoni I, Walsh C, Uryu S, et al. PND-1186 FAK inhibitor selectively promotes tumor cell apoptosis in three-dimensional environments. Cancer Biol Ther 2010; 9: 764-777.
87. Walsh C, Tanjoni I, Uryu S, et al. Oral delivery of PND-1186 FAK inhibitor decreases tumor growth and spontaneous breast to lung metastasis in pre-clinical models. Cancer Biol Ther 2010; 9(10): 778-790.
88. Ward KK, Tancioni I, Lawson C, et al. Inhibition of focal adhesion kinase (FAK) activity prevents anchorage-independent ovarian carcinoma cell growth and tumor progression. Clin Exp Metastasis 2013; 30(5): 579-594.
89. Eva A, Vecchio G, Rao CD, Tronick SR, Aaronson SA. The predicted DBL oncogene product defines a distinct class of transforming proteins. Proc Natl Acad Sci U S A 1988; 85(7): 2061-2065.
90. Barrio-Real L, Kazanietz MG. Rho GEFs and cancer: linking gene expression and metastatic dissemination. Sci Signal 2012; 5(244): p e43.
91. Shang X, Marchioni F, Evelyn CR, et al. Small-molecule inhibitors targeting G-protein-coupled Rho guanine nucleotide exchange factors. Proc Natl Acad Sci U S A 2013; 110(8): 3155-3160.
92. Konstantinidou G, Ramadori G, Torti F, et al. RHOA-FAK Is a Required Signaling Axis for the Maintenance of KRAS-Driven Lung Adenocarcinomas. Cancer Discov 2013; 3(4): 444-457.
93. Mitra SK, Lim ST, Chi A, Schlaepfer DD. Intrinsic focal adhesion kinase activity controls orthotopic breast carcinoma metastasis via the regulation of urokinase plasminogen activator expression in a syngeneic tumor model. Oncogene 2006; 25: 4429-4440.
94. Pylayeva Y, Gillen KM, Gerald W, Beggs HE, Reichardt LF, Giancotti FG. Ras- and PI3K-dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling. J Clin Invest 2009; 119(2): 252-266.
95. Weaver AM. Invadopodia: specialized cell structures for cancer invasion. Clin Exp Metastasis 2006; 23(2): 97-105.
96. Wang Y, McNiven MA. Invasive matrix degradation at focal adhesions occurs via protease recruitment by a FAK-p130Cas complex. J Cell Biol 2012; 196(3): 375-385.
97. Arnold K, Bordoli L, Kopp J, Schwede T. The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 2006; 22(2): 195-201.
98. Missy K, Hu B, Schilling K, et al. AlphaPIX Rho GTPase guanine nucleotide exchange factor regulates lymphocyte functions and antigen receptor signaling. Mol Cell Biol 2008; 28(11): 3776-3789.
99. Ramakers GJ, Wolfer D, Rosenberger G, et al. Dysregulation of Rho GTPases in the alphaPix/Arhgef6 mouse model of X-linked intellectual disability is paralleled by impaired structural and synaptic plasticity and cognitive deficits. Hum Mol Genet 2012; 21(2): 268-286.
100. Taymans JM. The GTPase function of LRRK2. Biochem Soc Trans 2012; 40(5): 1063-1069.
101. Kaartinen V, Gonzalez-Gomez I, Voncken JW, et al. Abnormal function of astroglia lacking Abr and Bcr RacGAPs. Development 2001; 128(21): 4217-4227.
102. Kaartinen V, Nagy A, Gonzalez-Gomez I, Groffen J, Heisterkamp N. Vestibular dysgenesis in mice lacking Abr and Bcr Cdc42/RacGAPs. Dev Dyn 2002; 223(4): 517-525.
103. Devon RS, Orban PC, Gerrow K, et al. Als2-deficient mice exhibit disturbances in endosome trafficking associated with motor behavioral abnormalities. Proc Natl Acad Sci U S A 2006; 103(25): 9595-9600.
104. Hadano S, Yoshii Y, Otomo A, et al. Genetic background and gender effects on gross phenotypes in congenic lines of ALS2/alsin-deficient mice. Neurosci Res 2010; 68(2): 131-136.
105. Arthur WT, Ellerbroek SM, Der CJ, Burridge K, Wennerberg K. XPLN, a guanine nucleotide exchange factor for RhoA and RhoB, but not RhoC. J Biol Chem 2002; 277(45): 42964-42972.
106. Serbanovic-Canic J, Cvejic A, Soranzo N, Stemple DL, Ouwehand WH, Freson K. Silencing of RhoA nucleotide exchange factor, ARHGEF3, reveals its unexpected role in iron uptake. Blood 2011; 118(18): 4967-4976.
107. Aoki T, Ueda S, Kataoka T, Satoh T. Regulation of mitotic spindle formation by the RhoA guanine nucleotide exchange factor ARHGEF10. BMC Cell Biol 2009; 10: 56.
108. Winkler S, Mohl M, Wieland T, Lutz S. GrinchGEF--a novel Rho-specific guanine nucleotide exchange factor. Biochem Biophys Res Commun 2005; 335(4): 1280-1286.
109. Oliver AW, He X, Borthwick K, Donne AJ, Hampson L, Hampson IN. The HPV16 E6 binding protein Tip-1 interacts with ARHGEF16, which activates Cdc42. Br J Cancer 2011; 104(2): 324-331.
110. Harada K, Hiramoto-Yamaki N, Negishi M, Katoh H. Ephexin4 and EphA2 mediate resistance to anoikis through RhoG and phosphatidylinositol 3-kinase. Exp Cell Res 2011; 317(12): 1701-17013.
111. Kawasaki Y, Jigami T, Furukawa S, et al. The Adenomatous Polyposis Coli-associated Guanine Nucleotide Exchange Factor Asef Is Involved in Angiogenesis. J Biol Chem 2010; 285(2): 1199-1207.
112. Kawasaki Y, Sagara M, Shibata Y, Shirouzu M, Yokoyama S, Akiyama T. Identification and characterization of Asef2, a guanine-nucleotide exchange factor specific for Rac1 and Cdc42. Oncogene 2007; 26(55): 7620-7627.
113. Kawasaki Y, Tsuji S, Muroya K, et al. The adenomatous polyposis coli-associated exchange factors Asef and Asef2 are required for adenoma formation in Apc(Min/+) mice. EMBO Rep 2009; 10(12): 1355-1362.
114. Cho YJ, Cunnick JM, Yi SJ, Kaartinen V, Groffen J, Heisterkamp N. Abr and Bcr, two homologous Rac GTPase-activating proteins, control multiple cellular functions of murine macrophages. Mol Cell Biol 2007; 27(3): 899-911.
115. Wang H, Li Y, Wang Y, Han ZG, Cai B. C9orf100, a new member of the Dbl-family guanine nucleotide exchange factors, promotes cell proliferation and migration in hepatocellular carcinoma. Mol Med Rep 2012; 5(5): 1169-1174.
116. Hirsch E, Pozzato M, Vercelli A, et al. Defective dendrite elongation but normal fertility in mice lacking the Rho-like GTPase activator Dbl. Mol Cell Biol 2002; 22(9): 3140-3148.
117. Whitehead LP, Lambert QT, Glaven JA, et al. Dependence of Dbl and Dbs transformation on MEK and NF-kappa B activation. Mol Cell Biol 1999; 19(11): 7759-7770.
118. Liu Z, Adams HC, 3rd, Whitehead IP. The rho-specific guanine nucleotide exchange factor Dbs regulates breast cancer cell migration. J Biol Chem 2009; 284(23): 15771-15780.
119. Salazar MA, Kwiatkowski AV, Pellegrini L, et al. Tuba, a novel protein containing bin/amphiphysin/Rvs and Dbl homology domains, links dynamin to regulation of the actin cytoskeleton. J Biol Chem 2003; 278(49): 49031-49043.
120. Srougi MC, Burridge K. The Nuclear Guanine Nucleotide Exchange Factors Ect2 and Net1 Regulate RhoB-Mediated Cell Death after DNA Damage. PLoS One 2011; 6(2): e17108.
121. Shi L, Butt B, Ip FCF, et al. Ephexin1 Is Required for Structural Maturation and Neurotransmission at the Neuromuscular Junction. Neuron 2010; 65(2): 204-216.
122. Koyano Y, Kawamoto T, Shen M, et al. Molecular cloning and characterization of CDEP, a novel human protein containing the ezrin-like domain of the band 4.1 superfamily and the Dbl homology domain of Rho guanine nucleotide exchange factors. Biochem Biophys Res Commun 1997; 241(2): 369-375.
123. Cheadle L, Biederer T. The novel synaptogenic protein Farp1 links postsynaptic cytoskeletal dynamics and transsynaptic organization. J Cell Biol 2012; 199(6): 985-1001.
124. Kubo T, Yamashita T, Yamaguchi A, Sumimoto H, Hosokawa K, Tohyama M. A novel FERM domain including guanine nucleotide exchange factor is involved in Rac signaling and regulates neurite remodeling. J Neurosci 2002; 22(19): 8504-8513.
125. Takegahara N, Kang S, Nojima S, et al. Integral roles of a guanine nucleotide exchange factor, FARP2, in osteoclast podosome rearrangements. FASEB J 2010; 24(12): 4782-4792.
126. He X, Kuo YC, Rosche TJ, Zhang X. Structural Basis for Autoinhibition of the Guanine Nucleotide Exchange Factor FARP2. Structure 2013; 21(3): 355-364.
127. Olson MF, Pasteris NG, Gorski JL, Hall A. Faciogenital dysplasia protein (FGD1) and Vav, two related proteins required for normal embryonic development, are upstream regulators of Rho GTPases. Curr Biol 1996; 6(12): 1628-1633.
128. Huber C, Martensson A, Bokoch GM, Nemazee D, Gavin AL. FGD2, a CDC42-specific exchange factor expressed by antigen-presenting cells, localizes to early endosomes and active membrane ruffles. J Biol Chem 2008; 283(49): 34002-34012.
129. Hayakawa M, Matsushima M, Hagiwara H, et al. Novel insights into FGD3, a putative GEF for Cdc42, that undergoes SCFFWD1/beta-TrCP-mediated proteasomal degradation analogous to that of its homologue FGD1 but regulates cell morphology and motility differently from FGD1. Genes Cells 2008; 13(4): 329-342.
130. Horn M, Baumann R, Pereira JA, et al. Myelin is dependent on the Charcot-Marie-Tooth Type 4H disease culprit protein FRABIN/FGD4 in Schwann cells. Brain 2012; 135: 3567-3583.
131. Cheng C, Haasdijk R, Tempel D, et al. Endothelial Cell-Specific FGD5 Involvement in Vascular Pruning Defines Neovessel Fate in Mice. Circulation 2012; 125(25): 3142-3158.
132. Aijaz S, D'Atri F, Citi S, Balda MS, Matter K. Binding of GEF-H1 to the tight junction-associated adaptor cingulin results in inhibition of Rho signaling and G1/S phase transition. Dev Cell 2005; 8(5): 777-786.
133. Li H, Oliver T, Jia W, He YW. Efficient dendritic cell priming of T lymphocytes depends on the extracellular matrix protein mindin. EMBO J 2006; 25(17): 4097-4107.
134. Reid T, Bathoorn A, Ahmadian MR, Collard JG. Identification and characterization of hPEM-2, a guanine nucleotide exchange factor specific for Cdc42. J Biol Chem 1999; 274(47): 33587-33593.
135. Shimojima K, Sugawara M, Shichiji M, et al. Loss-of-function mutation of collybistin is responsible for X-linked mental retardation associated with epilepsy. J Hum Genet 2011; 56(8): 561-565.
136. Hussain NK, Jenna S, Glogauer M, et al. Endocytic protein intersectin-l regulates actin assembly via Cdc42 and N-WASP. Nat Cell Biol 2001; 3(10): 927-932.
137. Yu Y, Chu PY, Bowser DN, et al. Mice deficient for the chromosome 21 ortholog Itsn1 exhibit vesicle-trafficking abnormalities. Hum Mol Genet 2008; 17(21): 3281-3290.
138. McGavin MK, Badour K, Hardy LA, Kubiseski TJ, Zhang J, Siminovitch KA. The intersectin 2 adaptor links Wiskott Aldrich Syndrome protein (WASp)-mediated actin polymerization to T cell antigen receptor endocytosis. J Exp Med 2001; 194(12): 1777-1787.
139. Cahill ME, Xie Z, Day M, et al. Kalirin regulates cortical spine morphogenesis and disease-related behavioral phenotypes. Proc Natl Acad Sci U S A 2009; 106(31): 13058-13063.
140. Wirth A, Benyo Z, Lukasova M, et al. G12-G13-LARG-mediated signaling in vascular smooth muscle is required for salt-induced hypertension. Nat Med 2008; 14(1): 64-68.
141. D'Angelo R, Aresta S, Blangy A, Del Maestro L, Louvard D, Arpin M. Interaction of ezrin with the novel guanine nucleotide exchange factor PLEKHG6 promotes RhoG-dependent apical cytoskeleton rearrangements in epithelial cells. Mol Biol Cell 2007; 18(12): 4780-4793.
142. Wu D, Asiedu M, Wei Q. Myosin-interacting guanine exchange factor (MyoGEF) regulates the invasion activity of MDA-MB-231 breast cancer cells through activation of RhoA and RhoC. Oncogene. 2009;28(22):2219-2230.
143. Alberts AS, Treisman R. Activation of RhoA and SAPK/JNK signalling pathways by the RhoA-specific exchange factor mNET1. EMBO J 1998; 17(14): 4075-4085.
144. Kawata H, Shimada N, Kamiakito T, et al. RhoC and guanine nucleotide exchange factor Net1 in androgen-unresponsive mouse mammary carcinoma SC-4 cells and human prostate cancer after short-term endocrine therapy. Prostate 2012; 72(10): 1071-1079.
145. Coisy-Quivy M, Touzet O, Bourret A, et al. TC10 controls human myofibril organization and is activated by the sarcomeric RhoGEF obscurin. J Cell Sci 2009; 122(Pt 7): 947-956.
146. Ford-Speelman DL, Roche JA, Bowman AL, Bloch RJ. The rho-guanine nucleotide exchange factor domain of obscurin activates rhoA signaling in skeletal muscle. Mol Biol Cell 2009; 20(17): 3905-3917.
147. Lange S, Ouyang K, Meyer G, et al. Obscurin determines the architecture of the longitudinal sarcoplasmic reticulum. J Cell Sci 2009; 122(Pt 15): 2640-2650.
148. Randazzo D, Giacomello E, Lorenzini S, et al. Obscurin is required for ankyrinB-dependent dystrophin localization and sarcolemma integrity. J Cell Biol 2013; 200(4): 523-536.
149. Welch HCE, Coadwell WJ, Ellson CD, et al. P-Rex1, a PtdIns(3,4,5)P-3- and G beta gamma-regulated guanine-nucleotide exchange factor for Rac. Cell 2002; 108(6): 809-821.
150. Dong X, Mo Z, Bokoch G, Guo C, Li Z, Wu D. P-Rex1 is a primary Rac2 guanine nucleotide exchange factor in mouse neutrophils. Curr Biol 2005; 15(20): 1874-1879.
151. Naikawadi RP, Cheng N, Vogel SM, et al. A critical role for phosphatidylinositol (3,4,5)-trisphosphate-dependent Rac exchanger 1 in endothelial junction disruption and vascular hyperpermeability. Circ Res 2012; 111(12): 1517-1527.
152. Qian F, Le Breton GC, Chen J, et al. Role for the guanine nucleotide exchange factor phosphatidylinositol-3,4,5-trisphosphate-dependent rac exchanger 1 in platelet secretion and aggregation. Arterioscler Thromb Vasc Biol 2012; 32(3): 768-777.
153. Rosenfeldt H, Vazquez-Prado J, Gutkind JS. P-REX2, a novel PI-3-kinase sensitive Rac exchange factor. FEBS Lett 2004; 572(1-3): 167-171.
154. Donald S, Humby T, Fyfe I, et al. P-Rex2 regulates Purkinje cell dendrite morphology and motor coordination. Proc Natl Acad Sci U S A 2008; 105(11): 4483-4488.
155. Niu J, Profirovic J, Pan H, Vaiskunaite R, Voyno-Yasenetskaya T. G Protein betagamma subunits stimulate p114RhoGEF, a guanine nucleotide exchange factor for RhoA and Rac1: regulation of cell shape and reactive oxygen species production. Circ Res 2003; 93(9): 848-856.
156. Mikelis CM, Palmby TR, Simaan M, et al. PDZ-RhoGEF and LARG are essential for embryonic development and provide a link between thrombin and LPA receptors and Rho activation. J Biol Chem 2013; 288(17): 12232-12243.
157. Rumenapp U, Freichel-Blomquist A, Wittinghofer B, Jakobs KH, Wieland T. A mammalian Rho-specific guanine-nucleotide exchange factor (p164-RhoGEF) without a pleckstrin homology domain. Biochem J 2002; 366(Pt 3): 721-728.
158. Mitin N, Rossman KL, Der CJ. Identification of a Novel Actin-Binding Domain within the Rho Guanine Nucleotide Exchange Factor TEM4. PLoS One 2012; 7(7): e41876.
159. Souchet M, Portales-Casamar E, Mazurais D, et al. Human p63RhoGEF, a novel RhoA-specific guanine nucleotide exchange factor, is localized in cardiac sarcomere. J Cell Sci 2002; 115(3): 629-640.
160. Rumenapp U, Blomquist A, Schworer G, Schablowski H, Psoma A, Jakobs KH. Rho-specific binding and guanine nucleotide exchange catalysis by KIAA0380, a Db1 family member. FEBS Lett 1999; 459(3): 313-318.
161. Ueda H, Nagae R, Kozawa M, et al. Heterotrimeric G protein betagamma subunits stimulate FLJ00018, a guanine nucleotide exchange factor for Rac1 and Cdc42. J Biol Chem 2008; 283(4): 1946-1953.
162. Lybaek H, Oyen N, Fauske L, Houge G. A 2.1 Mb deletion adjacent but distal to a 14q21q23 paracentric inversion in a family with spherocytosis and severe learning difficulties. Clin Genet 2008; 74(6): 553-559.
163. Griswold AJ, Ma DQ, Sacharow SJ, et al. A De Novo 1.5 Mb Microdeletion on Chromosome 14q23.2-23.3 in a Patient With Autism and Spherocytosis. Autism Res 2011; 4(3): 221-227.
164. Ishikawa K, Toru S, Tsunemi T, et al. An autosomal dominant cerebellar ataxia linked to chromosome 16q22.1 is associated with a single-nucleotide substitution in the 5 'untranslated region of the gene encoding a protein with spectrin repeat and Rho guanine-nucleotide exchange-factor domains. Am J Hum Genet 2005; 77(2): 280-296.
165. De Toledo M, Coulon V, Schmidt S, Fort P, Blangy A. The gene for a new brain specific RhoA exchange factor maps to the highly unstable chromosomal region 1p36.2-1p36.3. Oncogene 2001; 20(50): 7307-7317.
166. Maystadt I, Rezsohazy R, Barkats M, et al. The nuclear factor kappaB-activator gene PLEKHG5 is mutated in a form of autosomal recessive lower motor neuron disease with childhood onset. Am J Hum Genet 2007; 81(1): 67-76.
167. Fam NP, Fan WT, Wang Z, Zhang LJ, Chen H, Moran MF. Cloning and characterization of Ras-GRF2, a novel guanine nucleotide exchange factor for Ras. Mol Cell Biol 1997; 17(3): 1396-1406.
168. Brambilla R, Gnesutta N, Minichiello L, et al. A role for the Ras signalling pathway in synaptic transmission and long-term memory. Nature 1997; 390(6657): 281-286.
169. Itier JM, Tremp GL, Leonard JF, et al. Imprinted gene in postnatal growth role. Nature 1998; 393(6681): 125-126.
170. de Mora JF, Esteban LM, Burks DJ, et al. Ras-GRF1 signaling is required for normal beta-cell development and glucose homeostasis. EMBO J 2003; 22(12): 3039-3049.
171. Fernandez-Medarde A, Barhoum R, Riquelme R, et al. RasGRF1 disruption causes retinal photoreception defects and associated transcriptomic alterations. J Neurochem 2009; 110(2): 641-652.
172. Borras C, Monleon D, Lopez-Grueso R, et al. RasGrf1 deficiency delays dging in mice. Aging (Albany NY) 2011; 3(3): 262-276.
173. Fan WT, Koch CA, de Hoog CL, Fam NP, Moran MF. The exchange factor Ras-GRF2 activates Ras-dependent and Rac-dependent mitogen-activated protein kinase pathways. Curr Biol 1998; 8(16): 935-938.
174. Ruiz S, Santos E, Bustelo XR. RasGRF2, a guanosine nucleotide exchange factor for Ras GTPases, participates in T-cell signaling responses. Mol Cell Biol 2007; 27(23): 8127-8142.
175. Ellerbroek SM, Wennerberg K, Arthur WT, et al. SGEF, a RhoG guanine nucleotide exchange factor that stimulates macropinocytosis. Mol Biol Cell 2004; 15(7): 3309-3319.
176. Samson T, van Buul JD, Kroon J, et al. The Guanine-Nucleotide Exchange Factor SGEF Plays a Crucial Role in the Formation of Atherosclerosis. PLoS One 2013; 8(1): e55202.
177. Curtis C, Hemmeryckx B, Haataja L, Senadheera D, Groffen J, Heisterkamp N. Scambio, a novel guanine nucleotide exchange factor for Rho. Mol Cancer 2004; 3: 10.
178. Egan SE, Giddings BW, Brooks MW, Buday L, Sizeland AW, Weinberg RA. Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature 1993; 363: 45-51.
179. Nimnual AS, Yatsula BA, Bar-Sagi D. Coupling of Ras and Rac guanosine triphosphatases through the Ras exchanger Sos. Science 1998; 279(5350): 560-3.
180. Esteban LM, Fernandez-Medarde A, Lopez E, et al. Ras-guanine nucleotide exchange factor Sos2 is dispensable for mouse growth and development. Mol Cell Biol 2000; 20(17): 6410-6413.
181. Michiels F, Habets GG, Stam JC, van der Kammen RA, Collard JG. A role for Rac in Tiam1-induced membrane ruffling and invasion. Nature 1995; 375(6529): 338-340.
182. Yoo S, Kim Y, Lee H, Park S, Park S. A Gene Trap Knockout of the Tiam-1 Protein Results in Malformation of the Early Embryonic Brain. Mol Cells 2012; 34(1): 103-108.
183. Hoshinoso M, Sone M, Fukata M, et al. Identification of the stef gene that encodes a novel guanine nucleotide exchange factor specific for Rac1. J Biol Chem 1999; 274(25): 17837-17844.
184. Wang Z, Kumamoto Y, Wang P, et al. Regulation of Immature Dendritic Cell Migration by RhoA Guanine Nucleotide Exchange Factor Arhgef5. J Biol Chem 2009; 284(42): 28599-28606.
185. Fischer KD, Zmuldzinas A, Gardner S, Barbacid M, Bernstein A, Guidos C. Defective T-cell receptor signalling and positive selection of Vav-deficient CD4+ CD8+ thymocytes. Nature 1995; 374(6521): 474-477.
186. Tarakhovsky A, Turner M, Schaal S, et al. Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav. Nature 1995; 374(6521): 467-470.
187. Doody GM, Bell SE, Vigorito E, et al. Signal transduction through Vav-2 participates in humoral immune responses and B cell maturation. Nat Immunol 2001; 2(6): 542-547.
188. Sauzeau V, Jerkic M, Lopez-Novoa JM, Bustelo XR. Loss of Vav2 proto-oncogene causes tachycardia and cardiovascular disease in mice. Mol Biol Cell 2007; 18(3): 943-952.
189. Fujikawa K, Miletic AV, Alt FW, et al. Vav1/2/3-null mice define an essential role for Vav family proteins in lymphocyte development and activation but a differential requirement in MAPK signaling in T and B cells. J Exp Med 2003; 198(10): 1595-1608.
190. Quevedo C, Sauzeau V, Menacho-Marquez M, Castro-Castro A, Bustelo XR. Vav3-deficient mice exhibit a transient delay in cerebellar development. Mol Biol Cell 2010; 21(6): 1125-1139.
191. Kusuhara S, Fukushima Y, Fukuhara S, et al. Arhgef15 Promotes Retinal Angiogenesis by Mediating VEGF-Induced Cdc42 Activation and Potentiating RhoJ Inactivation in Endothelial Cells. PLoS One 2012; 7(9): e45858.
192. Wang Y, Suzuki H, Yokoo T, et al. WGEF is a novel RhoGEF expressed in intestine, liver, heart, and kidney. Biochem Biophys Res Commun 2004; 324(3): 1053-1058.